Galderma Group AGHere is the public summary page for Galderma Group AG. Please login to see the complete information for Galderma Group AG including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Galderma Group AG stacks up relative to its peers. |
| Darwin Score | +22 |
| Ticker | GALD |
| Latest Price | 125.30 CHF as of close on 11-Jul-2025 |
| 3 Month price range | 73.08 to 118.50 CHF |
| Market Capitalisation | 27.85Bn CHF |
| Country | Switzerland |
| Region | Europe |
| Description | Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services that span the spectrum of the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Dysport/Azzalure, Alluzience, Restylane, and Sculptra in injectable aesthetics; Cetaphil and Alastin in dermatological skincare; and Soolantra, Epiduo, Differin, Aklief, Epsolay, Twyneo, Oracea, Metvix, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland. See More ... |
| Company URL | https://www.galderma.com |
| See Darwins Full Analysis for Galderma Group AG |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Galderma Group AG. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +15 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | 0 |
| Models | Forecast models. | +8 |
Share 
